INO
Parece que los datos peor aún de lo esperado...
Red:
Data is tragically bad. First only 78% (1mg) and 84% (2mg) responded by seroconversion. 20% get no response. Holy shit is that bad. The titer in responders is 104. Yup it is as bad as was anticipated, in fact this is worse than I predicted last February. No wonder it took six months to publish this is garbage. This is a science experiment not a meaningful clinical trial. How sad is that, they have once again conned investors and played out the string for six months now. What a joke